Drug: LAMIVUDINE. Injury: Viral mutation identified Quarter: 2016Q3
Total Records: 17 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125664701 | LAMIVUDINE. | Viral mutation identified | GILEAD | 51.00 YR | M | 0 | 20160718 | CA |
| 125697051 | LAMIVUDINE. | Viral mutation identified | VIIV | 0.00 | M | 0 | 20160719 | CA |
| 125698861 | LAMIVUDINE. | Viral mutation identified | GLAXOSMITHKLINE | 0.00 | M | 0 | 20160719 | CA |
| 125882072 | LAMIVUDINE. | Viral mutation identified | GILEAD | 69.00 YR | M | 0 | 20160901 | CA |
| 126271942 | LAMIVUDINE. | Viral mutation identified | GILEAD | 47.00 YR | M | 0 | 20160809 | KR |
| 126422781 | LAMIVUDINE. | Viral mutation identified | GILEAD | 51.00 YR | F | 0 | 20160810 | KR |
| 126459841 | LAMIVUDINE. | Viral mutation identified | GILEAD | 30.00 YR | M | 0 | 20160811 | KR |
| 126641871 | LAMIVUDINE. | Viral mutation identified | GLAXOSMITHKLINE | 75.00 YR | M | 0 | 20160818 | CH |
| 126641891 | LAMIVUDINE. | Viral mutation identified | GLAXOSMITHKLINE | 53.00 YR | M | 0 | 20160818 | CH |
| 126642191 | LAMIVUDINE. | Viral mutation identified | VIIV | 75.00 YR | M | 0 | 20160818 | CH |
| 126642211 | LAMIVUDINE. | Viral mutation identified | VIIV | 53.00 YR | M | 0 | 20160818 | CH |
| 126706161 | LAMIVUDINE. | Viral mutation identified | BRISTOL MYERS SQUIBB | 53.00 YR | M | 0 | 20160822 | CH |
| 126959741 | LAMIVUDINE. | Viral mutation identified | GILEAD | 38.00 YR | M | 0 | 20160829 | KR |
| 127084491 | LAMIVUDINE. | Viral mutation identified | GLAXOSMITHKLINE | 60.00 YR | M | 0 | 20160901 | CN |
| 127086671 | LAMIVUDINE. | Viral mutation identified | VIIV | 60.00 YR | M | 0 | 20160901 | CN |
| 127200661 | LAMIVUDINE. | Viral mutation identified | VIIV | 56.00 YR | M | 0 | 20160907 | CN |
| 127203091 | LAMIVUDINE. | Viral mutation identified | GLAXOSMITHKLINE | 56.00 YR | M | 0 | 20160907 | CN |
Total Records: 17 Number of Pages: 1